Orthofix is an industry leader with a unique portfolio of limb reconstruction solutions, addressing the most challenging congenital, developmental, and acquired orthopedic conditions in patients of all ages.

Orthofix is the U.S. market leader with our PEMF technology bone growth stimulation systems, including various types of bone stimulators, indicated for post-operative spinal fusions and treating …

Our newly merged Orthofix-SeaSpine organization is a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, …

Orthofix said the spinal fixation device, which is set to launch in late 2010, is locked in place without the use of a torque wrench, which simplifies the procedure for surgeons.

Mar 2, 2026 · Orthofix Medical Inc. (NASDAQ:OFIX) is given the tenth position on our list of small-cap stocks. TheFly reported on February 26 that Canaccord reduced its price target for OFIX from $24 to …

4 days ago · Orthofix Medical (NASDAQ:OFIX) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a snapshot of …

3 days ago · Orthofix Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Orthofix Medical, Inc. – OFIX

4 days ago · Stifel Nicolaus cut their price target on shares of Orthofix Medical from $22.00 to $18.00 and set a "buy" rating for the company in a report on Monday.

Orthofix Bone Growth Therapy devices provide a safe, noninvasive treatment that helps promote healing in fractured bones and spinal fusions that have not healed or have difficulty healing.

Dec 29, 2004 · Orthofix was approved in 1985 to market a similar device for fractures in long bones like those in the leg and in 1998 for use in solidifying fusions in the lower, or lumbar, region of the spine.